NCT04984889 - A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

March 29, 2022

Study Completion Date

October 31, 2024

Conditions

Congenital Protein C Deficiency

Interventions

DRUG

TAK-662

Lyophilized, sterile concentrate of human protein C

Trial Locations (4)

Nara Medical University Hospital, Kashihara

Chiba Children's Hospital, Chiba

Chiba University Hospital, Chiba

Saitama Prefectural Children's Medical Center, Saitama